Ντουλοξετίνη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ντουλοξετίνη" in Greek language version.

refsWebsite

Global rank Greek rank

40nih.gov

4^th place

27doi.org

2^nd place

3^rd place

6fda.gov

447^th place

368^th place

5web.archive.org

1^st place

4worldcat.org

5^th place

8^th place

3drugs.com

399^th place

130^th place

3archive.org

6^th place

5^th place

2europa.eu

68^th place

24^th place

2clincalc.com

3,912^th place

594^th place

1prescrire.org

low place

1thelancet.com

2,393^rd place

1,822^nd place

1indystar.com

1,646^th place

5,169^th place

1cymbalta.com

low place

1lilly.com

low place

1medicines.org.uk

3,823^rd place

2,141^st place

archive.org

«Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & Rehabilitation». Muscle & Nerve 43 (6): 910–7. June 2011. doi:10.1002/mus.22092. PMID 21484835. https://archive.org/details/sim_muscle-nerve_2011-06_43_6/page/910.
«A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia». The Clinical Journal of Pain 25 (5): 365–75. June 2009. doi:10.1097/ajp.0b013e31819be587. PMID 19454869. https://archive.org/details/sim_clinical-journal-of-pain_2009-06_25_5/page/365.
«Block of neuronal Na+ channels by antidepressant duloxetine in a state-dependent manner». Anesthesiology 113 (3): 655–65. September 2010. doi:10.1097/ALN.0b013e3181e89a93. PMID 20693878. https://archive.org/details/sim_anesthesiology_2010-09_113_3/page/655.

clincalc.com

«The Top 300 of 2020». ClinCalc. Ανακτήθηκε στις 11 Απριλίου 2020.
«Duloxetine - Drug Usage Statistics». ClinCalc. Ανακτήθηκε στις 11 Απριλίου 2020.

cymbalta.com

«Eli Lilly and Company».

doi.org

dx.doi.org

«Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation». Neurology 76 (20): 1758–65. May 2011. doi:10.1212/WNL.0b013e3182166ebe. PMID 21482920.
«Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline». Journal of Clinical Oncology 32 (18): 1941–67. June 2014. doi:10.1200/JCO.2013.54.0914. PMID 24733808.
«[Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]» (στα German). Schmerz 26 (3): 297–310. June 2012. doi:10.1007/s00482-012-1172-2. PMID 22760463.
«Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & Rehabilitation». Muscle & Nerve 43 (6): 910–7. June 2011. doi:10.1002/mus.22092. PMID 21484835. https://archive.org/details/sim_muscle-nerve_2011-06_43_6/page/910.
«EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision». European Journal of Neurology 17 (9): 1113–e88. September 2010. doi:10.1111/j.1468-1331.2010.02999.x. PMID 20402746.
«Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia». The Cochrane Database of Systematic Reviews 1 (1): CD007115. January 2014. doi:10.1002/14651858.CD007115.pub3. PMID 24385423.
«Duloxetine versus other anti-depressive agents for depression». The Cochrane Database of Systematic Reviews 10: CD006533. October 2012. doi:10.1002/14651858.cd006533.pub2. PMID 23076926.
Geddes, John R.; Ioannidis, John P. A.; Tajika, Aran; Shinohara, Kiyomi; Imai, Hissei; Hayasaka, Yu; Takeshima, Nozomi; Egger, Matthias και άλλοι. (2018-04-07). «Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis». The Lancet 391 (10128): 1357–1366. doi:10.1016/S0140-6736(17)32802-7. ISSN 0140-6736. PMID 29477251. PMC 5889788. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32802-7/abstract.
«Duloxetine: a review of its use in the treatment of generalized anxiety disorder». CNS Drugs 23 (6): 523–41. 2009. doi:10.2165/00023210-200923060-00006. PMID 19480470.
«Generalized anxiety disorder». Annals of Internal Medicine 159 (11): ITC6–1, ITC6–2, ITC6–3, ITC6–4, ITC6–5, ITC6–6, ITC6–7, ITC6–8, ITC6–9, ITC6–10, ITC6–11; quiz ITC6–12. December 2013. doi:10.7326/0003-4819-159-11-201312030-01006. PMID 24297210.
«Duloxetine vs. placebo in patients with painful diabetic neuropathy». Pain 116 (1–2): 109–18. July 2005. doi:10.1016/j.pain.2005.03.029. PMID 15927394.
«A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain». Pain Medicine 6 (5): 346–56. 2005. doi:10.1111/j.1526-4637.2005.00061.x. PMID 16266355.
«Effects of treatments for symptoms of painful diabetic neuropathy: systematic review». BMJ 335 (7610): 87. July 2007. doi:10.1136/bmj.39213.565972.AE. PMID 17562735.
«Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials». BMC Neurology 8: 29. August 2008. doi:10.1186/1471-2377-8-29. PMID 18673529.
«Duloxetine for the treatment of fibromyalgia». Drugs of Today 44 (10): 725–34. October 2008. doi:10.1358/dot.2008.44.10.1269675. PMID 19137126.
«A systematic review of duloxetine for osteoarthritic pain: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?». Postgraduate Medicine 124 (1): 83–93. January 2012. doi:10.3810/pgm.2012.01.2521. PMID 22314118.
«The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis». BMC Musculoskeletal Disorders 15: 76. March 2014. doi:10.1186/1471-2474-15-76. PMID 24618328.
«Duloxetine 60 mg once daily in the treatment of milder major depressive disorder». International Journal of Clinical Practice 60 (5): 613–20. May 2006. doi:10.1111/j.1368-5031.2006.00956.x. PMID 16700869.
«A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia». The Clinical Journal of Pain 25 (5): 365–75. June 2009. doi:10.1097/ajp.0b013e31819be587. PMID 19454869. https://archive.org/details/sim_clinical-journal-of-pain_2009-06_25_5/page/365.
«The safety and tolerability of duloxetine compared with paroxetine and placebo: a pooled analysis of 4 clinical trials». Primary Care Companion to the Journal of Clinical Psychiatry 8 (4): 212–9. 2006. doi:10.4088/pcc.v08n0404. PMID 16964316.
«Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder». The Journal of Sexual Medicine 4 (4 Pt 1): 917–29. July 2007. doi:10.1111/j.1743-6109.2007.00520.x. PMID 17627739.
«Treatment-emergent sexual dysfunction with SSRIs and duloxetine: effectiveness and functional outcomes over a 6-month observational period». International Journal of Psychiatry in Clinical Practice 15 (4): 242–54. November 2011. doi:10.3109/13651501.2011.590209. PMID 22121997.
«SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants». CNS Spectrums 10 (9): 732–47. September 2005. doi:10.1017/s1092852900019726. PMID 16142213.
«The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression». Current Pharmaceutical Design 11 (12): 1475–93. 2005. doi:10.2174/1381612053764805. PMID 15892657.
«Block of neuronal Na+ channels by antidepressant duloxetine in a state-dependent manner». Anesthesiology 113 (3): 655–65. September 2010. doi:10.1097/ALN.0b013e3181e89a93. PMID 20693878. https://archive.org/details/sim_anesthesiology_2010-09_113_3/page/655.
Knadler, Mary Pat; Lobo, Evelyn; Chappell, Jill; Bergstrom, Richard (2011). «Duloxetine: clinical pharmacokinetics and drug interactions». Clinical Pharmacokinetics 50 (5): 281–294. doi:10.2165/11539240-000000000-00000. ISSN 1179-1926. PMID 21366359.
Fric, M.; Pfuhlmann, B.; Laux, G.; Riederer, P.; Distler, G.; Artmann, S.; Wohlschläger, M.; Liebmann, M. και άλλοι. (2008). «The influence of smoking on the serum level of duloxetine». Pharmacopsychiatry 41 (4): 151–155. doi:10.1055/s-2008-1073173. ISSN 0176-3679. PMID 18651344.

drugs.com

«Duloxetine». Drugs.com. Ανακτήθηκε στις 24 Δεκεμβρίου 2018.
«Duloxetine». Monograph. The American Society of Health-System Pharmacists. Ανακτήθηκε στις 24 Δεκεμβρίου 2018.
«Cymbalta - FDA prescribing information, side effects and uses». Drugs.com. https://www.drugs.com/pro/cymbalta.html. Ανακτήθηκε στις 2018-09-14.

europa.eu

ema.europa.eu

«Cymbalta EPAR». European Medicines Agency (EMA). Ανακτήθηκε στις 30 Σεπτεμβρίου 2020.
«Yentreve EPAR». European Medicines Agency (EMA). Ανακτήθηκε στις 30 Σεπτεμβρίου 2020.

fda.gov

Josefberg H (3 Σεπτεμβρίου 2004). «Application number 21-733. Medical review(s)» (PDF). U.S. Food and Drug Administration (FDA). Ανακτήθηκε στις 14 Απριλίου 2009. ^{[νεκρός σύνδεσμος]}
«Information for Healthcare Professionals: Duloxetine (marketed as Cymbalta) – Selective Serotonin Reuptake Inhibitors (SSRIs) or Selective Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) and 5-Hydroxytryptamine Receptor Agonists (Triptans)». U.S. Food and Drug Administration (FDA). 14 Αυγούστου 2013. Αρχειοθετήθηκε από το πρωτότυπο στις 7 Μαρτίου 2013. Ανακτήθηκε στις 18 Σεπτεμβρίου 2013.
«Antidepressants and Suicidality in Adults: Statistical Evaluation. (Presentation at Psychopharmacologic Drugs Advisory Committee; December 13, 2006)». Αρχειοθετήθηκε από το πρωτότυπο στις 27 Σεπτεμβρίου 2007. Ανακτήθηκε στις 13 Μαΐου 2007.
«Clinical review: relationship between antidepressant drugs and suicidality in adults» (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). U.S. Food and Drug Administration (FDA). 17 Νοεμβρίου 2006. σελίδες 11–74. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 16 Μαρτίου 2007. Ανακτήθηκε στις 22 Σεπτεμβρίου 2007.
«Statistical Evaluation of Suicidality in Adults Treated with Antidepressants» (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). U.S. Food and Drug Administration (FDA). 17 Νοεμβρίου 2006. σελίδες 75–140. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 16 Μαρτίου 2007. Ανακτήθηκε στις 22 Σεπτεμβρίου 2007.

accessdata.fda.gov

«Drug Approval Package: Cymbalta (duloxetine hydrochloride) NDA #022516». U.S. Food and Drug Administration (FDA). 16 Σεπτεμβρίου 2011. Ανακτήθηκε στις 29 Σεπτεμβρίου 2020. Lay summary (PDF).

indystar.com

Swiatek, Jeff (2013-10-13). «Loss of Cymbalta patent a major blow for Eli Lilly». Indianapolis Star. http://www.indystar.com/story/money/2013/12/10/loss-of-cymbalta-patent-a-major-blow-for-eli-lilly/3956997/. Ανακτήθηκε στις 2015-02-27.

lilly.com

pi.lilly.com

«Cymbalta product insert» (PDF).

medicines.org.uk

«Duloxetine 60mg gastro-resistant capsules - Summary of Product Characteristics (SmPC) - (emc)». www.medicines.org.uk. Αρχειοθετήθηκε από το πρωτότυπο στις 21 Μαρτίου 2020. Ανακτήθηκε στις 21 Μαρτίου 2020.

nih.gov

ncbi.nlm.nih.gov

«Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation». Neurology 76 (20): 1758–65. May 2011. doi:10.1212/WNL.0b013e3182166ebe. PMID 21482920.
«Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline». Journal of Clinical Oncology 32 (18): 1941–67. June 2014. doi:10.1200/JCO.2013.54.0914. PMID 24733808.
«[Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]» (στα German). Schmerz 26 (3): 297–310. June 2012. doi:10.1007/s00482-012-1172-2. PMID 22760463.
«Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & Rehabilitation». Muscle & Nerve 43 (6): 910–7. June 2011. doi:10.1002/mus.22092. PMID 21484835. https://archive.org/details/sim_muscle-nerve_2011-06_43_6/page/910.
«EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision». European Journal of Neurology 17 (9): 1113–e88. September 2010. doi:10.1111/j.1468-1331.2010.02999.x. PMID 20402746.
«Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia». The Cochrane Database of Systematic Reviews 1 (1): CD007115. January 2014. doi:10.1002/14651858.CD007115.pub3. PMID 24385423.
«Towards better patient care: drugs to avoid in 2014». Prescrire International 23 (150): 161–5. June 2014. PMID 25121155. http://english.prescrire.org/en/81/168/49342/0/NewsDetails.aspx.
«Duloxetine versus other anti-depressive agents for depression». The Cochrane Database of Systematic Reviews 10: CD006533. October 2012. doi:10.1002/14651858.cd006533.pub2. PMID 23076926.
Geddes, John R.; Ioannidis, John P. A.; Tajika, Aran; Shinohara, Kiyomi; Imai, Hissei; Hayasaka, Yu; Takeshima, Nozomi; Egger, Matthias και άλλοι. (2018-04-07). «Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis». The Lancet 391 (10128): 1357–1366. doi:10.1016/S0140-6736(17)32802-7. ISSN 0140-6736. PMID 29477251. PMC 5889788. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32802-7/abstract.
«Duloxetine: a review of its use in the treatment of generalized anxiety disorder». CNS Drugs 23 (6): 523–41. 2009. doi:10.2165/00023210-200923060-00006. PMID 19480470.
«Generalized anxiety disorder». Annals of Internal Medicine 159 (11): ITC6–1, ITC6–2, ITC6–3, ITC6–4, ITC6–5, ITC6–6, ITC6–7, ITC6–8, ITC6–9, ITC6–10, ITC6–11; quiz ITC6–12. December 2013. doi:10.7326/0003-4819-159-11-201312030-01006. PMID 24297210.
«Duloxetine vs. placebo in patients with painful diabetic neuropathy». Pain 116 (1–2): 109–18. July 2005. doi:10.1016/j.pain.2005.03.029. PMID 15927394.
«A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain». Pain Medicine 6 (5): 346–56. 2005. doi:10.1111/j.1526-4637.2005.00061.x. PMID 16266355.
«Effects of treatments for symptoms of painful diabetic neuropathy: systematic review». BMJ 335 (7610): 87. July 2007. doi:10.1136/bmj.39213.565972.AE. PMID 17562735.
«Duloxetine: new indication. Depression and diabetic neuropathy: too many adverse effects». Prescrire International 15 (85): 168–72. October 2006. PMID 17121211.
«Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials». BMC Neurology 8: 29. August 2008. doi:10.1186/1471-2377-8-29. PMID 18673529.
«Duloxetine for the treatment of fibromyalgia». Drugs of Today 44 (10): 725–34. October 2008. doi:10.1358/dot.2008.44.10.1269675. PMID 19137126.
«A systematic review of duloxetine for osteoarthritic pain: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?». Postgraduate Medicine 124 (1): 83–93. January 2012. doi:10.3810/pgm.2012.01.2521. PMID 22314118.
«The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis». BMC Musculoskeletal Disorders 15: 76. March 2014. doi:10.1186/1471-2474-15-76. PMID 24618328.
«Duloxetine 60 mg once daily in the treatment of milder major depressive disorder». International Journal of Clinical Practice 60 (5): 613–20. May 2006. doi:10.1111/j.1368-5031.2006.00956.x. PMID 16700869.
«A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia». The Clinical Journal of Pain 25 (5): 365–75. June 2009. doi:10.1097/ajp.0b013e31819be587. PMID 19454869. https://archive.org/details/sim_clinical-journal-of-pain_2009-06_25_5/page/365.
«The safety and tolerability of duloxetine compared with paroxetine and placebo: a pooled analysis of 4 clinical trials». Primary Care Companion to the Journal of Clinical Psychiatry 8 (4): 212–9. 2006. doi:10.4088/pcc.v08n0404. PMID 16964316.
«Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder». The Journal of Sexual Medicine 4 (4 Pt 1): 917–29. July 2007. doi:10.1111/j.1743-6109.2007.00520.x. PMID 17627739.
«Treatment-emergent sexual dysfunction with SSRIs and duloxetine: effectiveness and functional outcomes over a 6-month observational period». International Journal of Psychiatry in Clinical Practice 15 (4): 242–54. November 2011. doi:10.3109/13651501.2011.590209. PMID 22121997.
«SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants». CNS Spectrums 10 (9): 732–47. September 2005. doi:10.1017/s1092852900019726. PMID 16142213.
«The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression». Current Pharmaceutical Design 11 (12): 1475–93. 2005. doi:10.2174/1381612053764805. PMID 15892657.
Onuţu, Adela Hilda (2015). «Duloxetine, an antidepressant with analgesic properties – a preliminary analysis». Romanian Journal of Anaesthesia and Intensive Care 22 (2): 123–128. ISSN 2392-7518. PMID 28913467.
«Block of neuronal Na+ channels by antidepressant duloxetine in a state-dependent manner». Anesthesiology 113 (3): 655–65. September 2010. doi:10.1097/ALN.0b013e3181e89a93. PMID 20693878. https://archive.org/details/sim_anesthesiology_2010-09_113_3/page/655.
Knadler, Mary Pat; Lobo, Evelyn; Chappell, Jill; Bergstrom, Richard (2011). «Duloxetine: clinical pharmacokinetics and drug interactions». Clinical Pharmacokinetics 50 (5): 281–294. doi:10.2165/11539240-000000000-00000. ISSN 1179-1926. PMID 21366359.
Fric, M.; Pfuhlmann, B.; Laux, G.; Riederer, P.; Distler, G.; Artmann, S.; Wohlschläger, M.; Liebmann, M. και άλλοι. (2008). «The influence of smoking on the serum level of duloxetine». Pharmacopsychiatry 41 (4): 151–155. doi:10.1055/s-2008-1073173. ISSN 0176-3679. PMID 18651344.

pubmedcentral.nih.gov

«Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation». Neurology 76 (20): 1758–65. May 2011. doi:10.1212/WNL.0b013e3182166ebe. PMID 21482920.
«Duloxetine versus other anti-depressive agents for depression». The Cochrane Database of Systematic Reviews 10: CD006533. October 2012. doi:10.1002/14651858.cd006533.pub2. PMID 23076926.
Geddes, John R.; Ioannidis, John P. A.; Tajika, Aran; Shinohara, Kiyomi; Imai, Hissei; Hayasaka, Yu; Takeshima, Nozomi; Egger, Matthias και άλλοι. (2018-04-07). «Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis». The Lancet 391 (10128): 1357–1366. doi:10.1016/S0140-6736(17)32802-7. ISSN 0140-6736. PMID 29477251. PMC 5889788. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32802-7/abstract.
«Effects of treatments for symptoms of painful diabetic neuropathy: systematic review». BMJ 335 (7610): 87. July 2007. doi:10.1136/bmj.39213.565972.AE. PMID 17562735.
«Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials». BMC Neurology 8: 29. August 2008. doi:10.1186/1471-2377-8-29. PMID 18673529.
«The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis». BMC Musculoskeletal Disorders 15: 76. March 2014. doi:10.1186/1471-2474-15-76. PMID 24618328.
«Duloxetine 60 mg once daily in the treatment of milder major depressive disorder». International Journal of Clinical Practice 60 (5): 613–20. May 2006. doi:10.1111/j.1368-5031.2006.00956.x. PMID 16700869.
«The safety and tolerability of duloxetine compared with paroxetine and placebo: a pooled analysis of 4 clinical trials». Primary Care Companion to the Journal of Clinical Psychiatry 8 (4): 212–9. 2006. doi:10.4088/pcc.v08n0404. PMID 16964316.
Onuţu, Adela Hilda (2015). «Duloxetine, an antidepressant with analgesic properties – a preliminary analysis». Romanian Journal of Anaesthesia and Intensive Care 22 (2): 123–128. ISSN 2392-7518. PMID 28913467.

dailymed.nlm.nih.gov

«Cymbalta- duloxetine hydrochloride capsule, delayed release». DailyMed. Ανακτήθηκε στις 29 Σεπτεμβρίου 2020.

prescrire.org

english.prescrire.org

«Towards better patient care: drugs to avoid in 2014». Prescrire International 23 (150): 161–5. June 2014. PMID 25121155. http://english.prescrire.org/en/81/168/49342/0/NewsDetails.aspx.

thelancet.com

Geddes, John R.; Ioannidis, John P. A.; Tajika, Aran; Shinohara, Kiyomi; Imai, Hissei; Hayasaka, Yu; Takeshima, Nozomi; Egger, Matthias και άλλοι. (2018-04-07). «Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis». The Lancet 391 (10128): 1357–1366. doi:10.1016/S0140-6736(17)32802-7. ISSN 0140-6736. PMID 29477251. PMC 5889788. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32802-7/abstract.

web.archive.org

«Information for Healthcare Professionals: Duloxetine (marketed as Cymbalta) – Selective Serotonin Reuptake Inhibitors (SSRIs) or Selective Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) and 5-Hydroxytryptamine Receptor Agonists (Triptans)». U.S. Food and Drug Administration (FDA). 14 Αυγούστου 2013. Αρχειοθετήθηκε από το πρωτότυπο στις 7 Μαρτίου 2013. Ανακτήθηκε στις 18 Σεπτεμβρίου 2013.
«Antidepressants and Suicidality in Adults: Statistical Evaluation. (Presentation at Psychopharmacologic Drugs Advisory Committee; December 13, 2006)». Αρχειοθετήθηκε από το πρωτότυπο στις 27 Σεπτεμβρίου 2007. Ανακτήθηκε στις 13 Μαΐου 2007.
«Clinical review: relationship between antidepressant drugs and suicidality in adults» (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). U.S. Food and Drug Administration (FDA). 17 Νοεμβρίου 2006. σελίδες 11–74. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 16 Μαρτίου 2007. Ανακτήθηκε στις 22 Σεπτεμβρίου 2007.
«Statistical Evaluation of Suicidality in Adults Treated with Antidepressants» (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). U.S. Food and Drug Administration (FDA). 17 Νοεμβρίου 2006. σελίδες 75–140. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 16 Μαρτίου 2007. Ανακτήθηκε στις 22 Σεπτεμβρίου 2007.
«Duloxetine 60mg gastro-resistant capsules - Summary of Product Characteristics (SmPC) - (emc)». www.medicines.org.uk. Αρχειοθετήθηκε από το πρωτότυπο στις 21 Μαρτίου 2020. Ανακτήθηκε στις 21 Μαρτίου 2020.

worldcat.org

Geddes, John R.; Ioannidis, John P. A.; Tajika, Aran; Shinohara, Kiyomi; Imai, Hissei; Hayasaka, Yu; Takeshima, Nozomi; Egger, Matthias και άλλοι. (2018-04-07). «Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis». The Lancet 391 (10128): 1357–1366. doi:10.1016/S0140-6736(17)32802-7. ISSN 0140-6736. PMID 29477251. PMC 5889788. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32802-7/abstract.
Onuţu, Adela Hilda (2015). «Duloxetine, an antidepressant with analgesic properties – a preliminary analysis». Romanian Journal of Anaesthesia and Intensive Care 22 (2): 123–128. ISSN 2392-7518. PMID 28913467.
Knadler, Mary Pat; Lobo, Evelyn; Chappell, Jill; Bergstrom, Richard (2011). «Duloxetine: clinical pharmacokinetics and drug interactions». Clinical Pharmacokinetics 50 (5): 281–294. doi:10.2165/11539240-000000000-00000. ISSN 1179-1926. PMID 21366359.
Fric, M.; Pfuhlmann, B.; Laux, G.; Riederer, P.; Distler, G.; Artmann, S.; Wohlschläger, M.; Liebmann, M. και άλλοι. (2008). «The influence of smoking on the serum level of duloxetine». Pharmacopsychiatry 41 (4): 151–155. doi:10.1055/s-2008-1073173. ISSN 0176-3679. PMID 18651344.